Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11878224 | 0.79 | CYP3A4 (0.47) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL109280 | 0.77 | CYP3A4 (0.62) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL10624633 | 0.76 | CYP3A4 (0.47) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL28211238 | 0.74 | GABRA1 (0.45) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL29648814 | 0.72 | CYP3A4 (0.47) | CYP3A4 | |
| SCHEMBL9630070 | 0.72 | CYP3A4 (0.52) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL30625397 | 0.72 | CYP3A4 (0.52) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL75112 | 0.72 | CYP3A4 (0.47) | CYP3A4 | |
| SCHEMBL4242346 | 0.71 | CYP3A4 (0.47) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL59215 | 0.71 | CYP3A4 (0.47) | CYP3A4GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023684-B2 | Universal spot blender for one-component and two-component clearcoatings | BASF COATINGS GMBH (DE) | 2018-07-17 | — | — | US | claimed |
| EP-4376997-A1 | BIODEGRADABLE MICROCAPSULES | International Flavors & Fragrances Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| WO-2023196942-A1 | FLEXIBLE LAMINATES INCLUDING POLYURETHANE ADHESIVE COMPOSITIONS AND ENERGY STORAGE DEVICES INCLUDING THE SAME | H.B. FULLER COMPANY (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023009514-A1 | BIODEGRADABLE MICROCAPSULES | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| US-11351096-B2 | Organic compounds | GIVAUDAN SA (CH) | 2022-06-07 | — | — | US | disclosed |
| CN-114555713-A | One-part moisture-curable silicone composition | 汉高股份有限及两合公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-107428785-B | Silanes and curable compositions containing silanes as crosslinkers | 汉高股份有限及两合公司 | 2021-05-07 | — | — | CN | disclosed |
| US-20210030639-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2021-02-04 | — | — | US | disclosed |
| EP-3765160-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2021-01-20 | — | — | EP | disclosed |
| CN-111836668-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| CN-111386323-A | System for applying base coats and bonding floor coverings | 科思创德国股份有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-107360721-B | Curable polymeric compositions | 汉高股份有限及两合公司 | 2020-07-03 | — | — | CN | disclosed |
| WO-2019174978-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2019-09-19 | — | — | WO | disclosed |
| EP-3215103-A1 | MICROCAPSULES COMPRISING HYDROXYALKYL CELLULOSE | BASF SE (DE) | 2017-09-13 | — | — | EP | disclosed |
| WO-2016071153-A1 | MICROCAPSULES COMPRISING HYDROXYALKYL CELLULOSE | BASF SE (DE) | 2016-05-12 | — | — | WO | disclosed |
| US-20100136347-A1 | TWO COMPONENT SOLVENTLESS POLYURETHANE LAMINATING ADHESIVES BASED ON 1,4:3,6 DIANHYDROHEXITOLS | SIMONS J BRANDON SIMONS | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11351096-B2 | Organic compounds | AUP1, SAMM50, PCBP1 | CYP3A4 767/4885GABRA1 3041/4885GABRB2 3257/4885 |
| US-20210030639-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AUP1, PCBP1, NOTUM | CYP3A4 988/4885GABRA1 3534/4885GABRB2 3440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.